Deep Tests
Generalized anxiety self-assessment · GAD-7 · 10 min

Anxiety test

Adult anxiety self-assessment based on the GAD-7 (Spitzer, Kroenke, Williams & Löwe, 2006). In 10 minutes, you get your severity score and a differential read on depression, panic, social anxiety, and trauma.

10 min 31 questions anxiety

GAD-7

What this test explores

Profile analysis by dimension
Identification of your main tendencies
Comparison against reference data
Personalised reflection prompts
Probable sub-type (premium results)
Tips and next steps

Ready to understand yourself better?

Discover your profile in minutes with a scientifically validated test.

Free · instant results

The test includes

  • About 10 minutes
  • 31 questions
  • Analysis by dimension
  • Profile result

Access

  • Online, at your own pace
  • Unlimited retakes
  • Updated: April 2026

The generalized anxiety test is a free self-assessment built on the GAD-7 (Spitzer et al., 2006). In 10 minutes, 27 to 31 questions (depending on which conditional follow-ups apply), you get your GAD-7 score (0–21) classed into the 4 standard severity tiers — minimal, mild, moderate, severe — plus a differential read on depression, panic, social anxiety, and post-traumatic stress. It's not a medical diagnosis. Reviewed by our editorial team referencing peer-reviewed sources.

How it works

Four steps, about ten minutes, zero friction before results.

  1. 1

    Informed consent

    You acknowledge that this is a screening tool, not a diagnosis. No personal data required to start — no email, no sign-up. Your answers stay in your browser until you request the premium report.

  2. 2

    27 to 31 questions in 10 minutes

    Six chapters across roughly 10 minutes — context, worry, body and tension, anticipatory fear, life impact, differential. The 7 core items follow the GAD-7 (Spitzer et al., 2006) on a 2-week recall window. You can navigate back at any time.

  3. 3

    Instant scoring

    Your GAD-7 score (0–21), your severity tier, and your sub-type read — cognitive worry, somatic arousal, anticipatory fear — are calculated as soon as you finish. No wait, no email required to see your results.

  4. 4

    Premium dimensional analysis

    The premium report adds per-dimension interpretation, a differential read across the 4 neighbouring tracks (depression, panic, social anxiety, post-traumatic stress) and concrete next-step recommendations tailored to your generalized anxiety profile.

What this test is based on

This test builds on the Generalized Anxiety Disorder 7-item scale (GAD-7), published in 2006 by Spitzer, Kroenke, Williams and Löwe in Archives of Internal Medicine. Each of its 7 items maps to DSM-5-TR markers for generalized anxiety disorder (APA, 2022), anchored to a 2-week recall window. The instrument is © Pfizer Inc. and free for clinical, research, and educational use under Pfizer's free-use license — no permission required, attribution mandatory.

The DSM-5-TR defines generalized anxiety disorder as excessive worry, more days than not for at least 6 months, that the person finds difficult to control, paired with three or more associated symptoms (restlessness, fatigue, concentration trouble, irritability, muscle tension, sleep disturbance) and clinically significant impairment in social, occupational, or other important areas of functioning. Beyond the GAD-7, you answer a short context chapter (age, current situation, symptom duration) and a differential chapter that explores other possible leads — depression, panic, social anxiety, post-traumatic stress — so the report can flag what may look like generalized anxiety without being it.

Spitzer et al. (2006) reported a sensitivity of 89% and a specificity of 82% for generalized anxiety disorder at the ≥ 10 cutoff against a structured interview with a mental health professional (N = 2 740 primary-care patients). Plummer et al. (2016, General Hospital Psychiatry, meta-analysis of 12 studies) reported pooled sensitivity around 83% and specificity around 84% at the same cutoff across diverse populations — consistent across primary-care, hospital, and community samples. The GAD-7 is the screening instrument recommended by primary-care bodies worldwide and used by clinicians to monitor treatment response between visits.

A few numbers for context: per the NIMH generalized anxiety disorder page (2024), GAD affects a meaningful share of US adults each year, and the NHS (2024) reports that generalized anxiety disorder is among the most common anxiety disorders in UK adults. Across population studies, women are about twice as likely as men to develop generalized anxiety disorder — a stable signal across countries. The WHO (2024) underlines that anxiety disorders are the most common mental-disorder category worldwide. On the treatment side, cognitive behavioural therapy (CBT) is the first-line treatment for generalized anxiety disorder per NIMH and NHS guidance; SSRIs and SNRIs are also used in first-line pharmacotherapy. Benzodiazepines (GABAergic anxiolytics) are not recommended for long-term GAD management — short, time-limited use only, given dependence risk. Early treatment markedly improves outcomes — best discussed with a health professional.

Three GAD-7 severity tiers

The GAD-7 classes your total score (0–21) into severity tiers published by Spitzer et al. (2006). Your tier indicates the recommended level of clinical attention — this reading is detailed in the premium report.

Severe (15–21)

Scores in this range suggest severe generalized anxiety. The course recommended by Spitzer and colleagues is active treatment with CBT and/or pharmacotherapy and a specialist referral. Don't wait — generalized anxiety responds well to evidence-based treatment.

  • Marked, persistent symptoms of generalized anxiety nearly every day over the last 2 weeks
  • Significant impact on work, close relationships, sleep, and avoidance behaviours
  • Most DSM-5-TR GAD criteria likely met with high intensity — specialist evaluation strongly recommended

Moderate (10–14)

Scores in this range suggest a clinically significant generalized anxiety picture. This is the standard primary-care alert threshold (sensitivity 89%, specificity 82% at the ≥ 10 cutoff per Spitzer 2006): the recommended course is further evaluation, brief counselling or structured CBT, and regular follow-up.

  • Excessive worry and tension present more than half the days
  • Trouble relaxing, restlessness, irritability that weigh on work and relationships
  • GAD-7 ≥ 10 — the recognised threshold for further generalized anxiety evaluation

Mild (5–9)

Scores in this range suggest mild, intermittent generalized anxiety symptoms below the clinical cutoff. The course recommended by Spitzer and colleagues is watchful waiting and self-care: retake the GAD-7 in 2 to 4 weeks to track how things evolve, and consult if symptoms worsen or persist.

  • A few days of passing worry or tension, without settling in across all days
  • Sleep, focus, and mood broadly preserved across day-to-day life
  • Good preventive-intervention window — sleep hygiene, exercise, reduced caffeine work

Who this test is for

This generalized anxiety test is designed for adults aged 18+ who have questions about their worry patterns — with or without a prior diagnosis.

  • Adults who can't stop worrying about everything — work, money, health, loved ones, the future — and want to clarify whether their pattern matches generalized anxiety disorder before seeing a clinician
  • People in chronic stress or potential burnout who want to tell apart situational pressure from a generalized anxiety picture that warrants follow-up
  • Caregivers, parents, or anyone stretched thin by mental load who notice persistent tension, sleep disturbance, and irritability and want a structured first read on their generalized anxiety symptoms
  • Students or young professionals navigating uncertainty who recognise themselves in excessive worry, restlessness, or anticipatory fear and want a confidential first overview
  • People with a prior generalized anxiety history seeking objectivity — the GAD-7 is the most widely used screening tool to monitor how generalized anxiety symptoms evolve between consultations

Frequently asked questions

Avertissement

<strong>GAD-7 © Pfizer Inc.</strong> — free-use license for clinical, research, and educational purposes (no permission required for use, reproduction, translation, or display; not public domain). Items authored by Spitzer, Kroenke, Williams & Löwe (Arch Intern Med, 2006). This test is a screening tool, not a medical diagnosis. If your results or difficulties concern you, consult a health professional. If you're in a suicidal crisis, call 988 (US / Canada), 116 123 (UK / EU), 13 11 14 (Australia), Belgium 0800 32 123 (Centre de Prévention du Suicide), Quebec 1 866 APPELLE / 1 866 277-3553, Switzerland 143 (La Main Tendue), or your local emergency number.

Sources

Explore all our tests and get to know yourself better

Join thousands of people who took their first step toward a better self-understanding with our scientifically validated tests.

Explore all tests
fren